OGI Invests in Personalized Medicine for Age-related Macular Degeneration - November 1,... - 0 views
-
Cathy Bogaart on 02 Nov 10The Ontario Genomics Institute has given funding to MaRS life sciences client, ArcticDX. They'll use the money for studies in preparation for a Food and Drug Administration approval for their product. The funding comes through its Pre-Commercialization Business Development Fund (PBDF)